Gene Biotherapeutics Inc (CRXM)
0.00
USD |
OTCM |
May 03, 16:00
Gene Biotherapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2014 | 4.480 |
| September 26, 2014 | 4.815 |
| September 25, 2014 | 4.813 |
| September 24, 2014 | 4.861 |
| September 23, 2014 | 4.702 |
| September 22, 2014 | 4.624 |
| September 19, 2014 | 4.626 |
| September 18, 2014 | 4.032 |
| September 17, 2014 | 4.253 |
| September 16, 2014 | 4.144 |
| September 15, 2014 | 4.435 |
| September 12, 2014 | 4.346 |
| September 11, 2014 | 4.365 |
| September 10, 2014 | 4.257 |
| September 09, 2014 | 4.797 |
| September 08, 2014 | 4.704 |
| September 05, 2014 | 4.783 |
| September 04, 2014 | 4.783 |
| September 03, 2014 | 4.783 |
| September 02, 2014 | 4.480 |
| August 29, 2014 | 4.703 |
| August 28, 2014 | 4.808 |
| August 27, 2014 | 5.085 |
| August 26, 2014 | 5.151 |
| August 25, 2014 | 4.872 |
| Date | Value |
|---|---|
| August 22, 2014 | 5.319 |
| August 21, 2014 | 5.319 |
| August 20, 2014 | 5.368 |
| August 19, 2014 | 5.376 |
| August 18, 2014 | 5.656 |
| August 15, 2014 | 5.656 |
| August 14, 2014 | 5.656 |
| August 13, 2014 | 5.488 |
| August 12, 2014 | 5.488 |
| August 11, 2014 | 5.488 |
| August 08, 2014 | 5.600 |
| August 07, 2014 | 5.824 |
| August 06, 2014 | 5.824 |
| August 05, 2014 | 5.812 |
| August 04, 2014 | 5.754 |
| August 01, 2014 | 5.763 |
| July 31, 2014 | 5.763 |
| July 30, 2014 | 5.765 |
| July 29, 2014 | 5.544 |
| July 28, 2014 | 5.766 |
| July 25, 2014 | 6.098 |
| July 24, 2014 | 5.864 |
| July 23, 2014 | 6.099 |
| July 22, 2014 | 6.263 |
| July 21, 2014 | 6.653 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.116 |
| Perspective Therapeutics Inc | 14.13 |
| Protalix BioTherapeutics Inc | 2.481 |
| Electromed Inc | 3.946 |
| Armata Pharmaceuticals Inc | -- |